International Journal of Head and Neck Surgery

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2012 ) > List of Articles

RESEARCH ARTICLE

Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy

Sonal Vahanwala, Sukhjinder Kaur Khosa, Sandeep S Pagare

Citation Information : Vahanwala S, Khosa SK, Pagare SS. Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy. Int J Head Neck Surg 2012; 3 (1):1-4.

DOI: 10.5005/jp-journals-10001-1079

Published Online: 01-04-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Khosa SK, Vahanwala S, Pagare SS. Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy. Int J Head and Neck Surg 2012;3(1):1-4.


PDF Share
  1. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. The Oncologist, December 1999;4(6): 433-42.
  2. Isolation and identification of Candida from the oral cavity. Oral Dis 2000;6;3-11.
  3. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. J Am Dent Assoc 1997;128:1128-33.
  4. Xerstomia: Aetiology and management in cancer patients. Support Care Cancer 1998;6:348-55.
  5. Intensity-modulated radiation therapy (IMRT): A clinical perspective. Introduction. Semin Radiat Oncol 2002;12:197-98.
  6. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-32.
  7. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87.
  8. Evaluation of parotid gland function following intensity-modulated radiotherapy for head and neck cancer. Cancer Res Treat 2006;38(2):84-91.
  9. Intensity-modulated radiation therapy (IMRT): The most important advance in radiotherapy since the linear accelerator. The British Journal of Radiology 2003;76:673.
  10. Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study. J Clin Oncol 2000 June; 18(11):2226-33.
  11. Sialogoguerelated radioprotection of salivary gland function: The degranulation concept revisited. Radiat Res Sep 1997;148(3): 240-47.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.